Urological Chronic Pelvic Pain Syndrome Flares and Their Impact

Qualitative Analysis in the MAPP Network

Published in: International Urogynecology Journal, v. 26, no. 7, July 2015, p. 1047-1060

Posted on RAND.org on April 07, 2015

by Siobhan Sutcliffe, Catherine S. Bradley, J. Quentin Clemens, Aimee S. James, Katy S. Konkle, Karl J. Kreder, Hing Hung Lai, Sean C. Mackey, Cody P. Ashe-McNalley, Larissa V. Rodriguez, Edward Barrell, Xiaoling Hou, Nancy A. Robinson, Christopher Mullins, Sandra H. Berry

Read More

Access further information on this document at rd.springer.com

This article was published outside of RAND. The full text of the article can be found at the link above.

INTRODUCTION AND HYPOTHESIS: Although in-depth qualitative information is critical to understanding patients' symptom experiences and to developing patient-centered outcome measures, only one previous qualitative study has assessed urological chronic pelvic pain syndrome (UCPPS) symptom exacerbations ("flares"). METHODS: We conducted eight focus groups of female UCPPS (interstitial cystitis/bladder pain syndrome) patients at four sites from the MAPP Research Network (n = 57, mean = 7/group) to explore the full spectrum of flares and their impact on patients' lives. RESULTS: Flare experiences were common and varied widely in terms of UCPPS symptoms involved, concurrent nonpelvic symptoms (e.g., diarrhea), symptom intensity (mild to severe), duration (minutes to years), and frequency (daily to < once/year), although the most commonly described flares were painful flares lasting days. These latter flares were also most disruptive to participants' lives, causing some to cancel social events, miss work or school, and in the worst cases, go to the emergency room or on disability leave. Participants also reported a longer-term impact of flares, including negative effects on their sexual functioning and marital, family, and social relationships; and the loss of employment or limited career or educational advancement. Emerging themes included the need for a sense of control over unpredictable symptoms and reduced social engagement. CONCLUSIONS: Given their negative impact, future research should focus on approaches to prevent flares, and to reduce their frequency, severity, and/or duration. Patients' quality of life may also be improved by providing them with a sense of control over their symptoms through ready access to flare medications/therapy, and by engaging them socially.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.